SOURCE: General Cannabis, Inc.

General Cannabis, Inc.

September 01, 2011 08:00 ET

WeedMaps Media Finalizes Licensing Agreement With SC Laboratories and Launches Cannabis Testing

NEWPORT BEACH, CA--(Marketwire - Sep 1, 2011) - General Cannabis, Inc. (OTCQX: CANA) (PINKSHEETS: CANA), a technology-based Internet marketing services company, today announced that WeedMaps Media has finalized a licensing agreement with SC Laboratories for cannabis testing services. SC Laboratories will leverage WeedMaps' extensive marketing portal to offer medicinal cannabis patients relevant information about the quality and strength of their medicine.

"Through this agreement, WeedMaps and SC Laboratories will make testing the new standard in the cannabis industry. Patients can now go to WeedMaps.com to select the best tested medicine specifically for their own medicinal needs, in addition to finding local dispensaries and the best deals," said Doug Francis, President and Chief Strategy Officer of General Cannabis. "Quality matters, especially for patients with acute pain and discomfort, and now it can be quantifiably measured by turning to SC Labs' Test results on WeedMaps.com."

Josh Wurzer, Laboratory Director for SC Laboratories, commented, "WeedMaps and SC Labs will seek to educate and move our industry toward a higher standard of service, where potency testing, standardized dosing, and quality assurance testing for pesticides, fungicides and microbiological contamination become widely accepted and acknowledged industry standards."

Among the first independent analytical institutions to recognize the importance of promoting cannabis safety through education, testing and certification, SC Laboratories provides a comprehensive testing array for pesticide and microbiological contamination, as well as strain potency analysis. SC Laboratories utilizes High Performance Liquid Chromatography with a Diode Array Detector (HPLC-DAD,) for potency testing. HPLC has become the standard for potency testing over the older GC technology. HPLC does not use heat, therefore making it possible to determine the levels of acidic cannabinoids (the major constituents of raw medical cannabis) as they are found in the plant. Accurate cannabinoid profiling allows patients a better gauge for standardizing dosage.

Click here to join Justin Hartfield, Chief Web Officer of WeedMaps Media, for a tour of SC Laboratories' testing facility in Capitola, CA (via WeedMaps.TV): http://www.scanalytical.com/news.html

About General Cannabis

General Cannabis, Inc. (OTCQX: CANA) (PINKSHEETS: CANA), a technology-based Internet marketing services company, offers customers an integrated suite of services including media, technology, marketing and information. Founded in 2010, General Cannabis is headquartered in Newport Beach, California. www.GeneralCannabis.com

About SC Laboratories

SC Laboratories is one of the first independent analytical institutions to recognize the importance of promoting cannabis safety through education, testing and certification. SC Laboratories utilizes state-of-the-art scientific instruments to analyze the potency, determine the microbiological safety, as well as look for pesticide residues on medical cannabis. SC Labs follows the same methods already established by the Dutch Pharmacopeia (MOBEC) and the United Nations Office on Drugs and Crime. www.scanalytical.com

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). General Cannabis, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. General Cannabis, Inc. undertakes no obligation to revise these statements following the date of this news release.